The company known as LIFETECH SCI (01302) has issued a profit warning to the stock exchange. Excluding several non-recurring items, the group anticipates a net profit attributable to equity holders of between RMB 110 million and RMB 120 million for the six months ending June 30, 2026.

This figure represents a significant decline compared to the net profit attributable to equity holders of approximately RMB 238.5 million recorded in the same period of 2025.

The forecasted decrease in core profit is primarily driven by two factors: a drop in revenue and a substantial reduction in net foreign exchange gains.

The non-recurring items mentioned include share-based payment expenses, other gains and losses from financial assets measured at fair value through profit or loss, and anticipated transaction costs related to a major transaction involving the acquisition of equity in Beijing Huayi Shengjie Technology Co., Ltd. and the issuance of convertible bonds. The company's board of directors has resolved not to proceed with this major transaction.

After accounting for the impact of these non-recurring items, the group expects to report a loss attributable to equity holders of between RMB 30 million and RMB 40 million for the six months ending June 30, 2026. This contrasts with a net profit attributable to equity holders of approximately RMB 55.1 million reported for the same period in 2025.